Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

3.0K
The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
3.0K
Motor Unit Stimulation01:20

Motor Unit Stimulation

1.4K
When the neuron of a motor unit fires an action potential, it triggers a series of events, leading to a twitch contraction in the muscle fibers. The process of excitation-contraction coupling is crucial in relaying the action potential to the muscle fibers.
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
1.4K
Muscle Contraction01:10

Muscle Contraction

6.2K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
6.2K
Cross-bridge Cycle01:26

Cross-bridge Cycle

116.8K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
116.8K
Muscle Stimulation Frequency01:22

Muscle Stimulation Frequency

2.0K
The contraction strength of muscles is regulated by motor neurons, which modulate the frequency of action potentials dispatched to the motor units based on the body's requirements. This process of varying the muscle stimulation frequency allows muscles to contract with a force that is precisely tailored to the needs of the moment, whether lifting a feather or a heavy box.
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
2.0K
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

2.3K
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensions.

Therapeutic advances in neurological disorders·2026
Same author

Health-related quality of life outcomes with nipocalimab versus placebo in generalized myasthenia gravis: an analysis of the Vivacity-MG3 study.

Journal of neurology·2026
Same author

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Brain : a journal of neurology·2026
Same author

Clinical effectiveness of efgartigimod in a broad population of patients with generalized myasthenia gravis: subgroup analyses from a randomized, double‑blind, placebo‑controlled, phase 3 trial (ADAPT).

Journal of neurology·2026
Same author

Natural history of cardiac involvement in women carrying pathogenic DMD gene variants: a 7-year longitudinal study.

Journal of neurology·2026
Same author

Prevalence and characteristics of patients with seronegative myasthenia gravis.

Journal of neurology·2026
Same journal

Late-Onset Myasthenia Gravis: An Increasingly Frequent Clinical Entity With Distinctive Challenges.

Muscle & nerve·2026
Same journal

Clinical Characteristics and Treatment Management of Seronegative Myasthenia Gravis: A Systematic Review of the Literature.

Muscle & nerve·2026
Same journal

Muscle-Specific Kinase Signaling and Its Therapeutic Potential.

Muscle & nerve·2026
Same journal

Optimization of the Cell-Based Assay Methodology to Study Degradation of Acetylcholine Receptors (Antigenic Modulation) by Antibodies From Myasthenia Gravis Patients.

Muscle & nerve·2026
Same journal

Review of Congenital Myasthenic Syndrome Caused by Pathogenic Variants in GFPT1.

Muscle & nerve·2026
Same journal

Accuracy of Palpation-Guided Versus First Attempt at Ultrasound-Guided Electromyography Needle Placement for the Extensor Carpi Radialis Longus and Brevis by Trainees.

Muscle & nerve·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2025

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

23.7K

Muscle Contractility in Hypokalemic Periodic Paralysis.

Sonja Holm-Yildiz1, Thomas Krag1, Tina Dysgaard1

  • 1Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Muscle & Nerve
|December 24, 2024
PubMed
Summary
This summary is machine-generated.

Primary hypokalemic periodic paralysis (HypoPP) causes muscle weakness due to fat replacement and decreased muscle contractility in patients with CACNA1S variants. Further research is needed to understand the exact mechanisms.

Keywords:
Dixon MRIfat replacementhypokalemic periodic paralysismuscle MRImuscle contractility

More Related Videos

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
06:22

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice

Published on: September 17, 2015

14.9K
Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties
08:27

Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties

Published on: February 19, 2020

14.1K

Related Experiment Videos

Last Updated: Jun 4, 2025

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

23.7K
Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
06:22

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice

Published on: September 17, 2015

14.9K
Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties
08:27

Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties

Published on: February 19, 2020

14.1K

Area of Science:

  • Neurology
  • Muscle Physiology
  • Medical Imaging

Background:

  • Primary hypokalemic periodic paralysis (HypoPP) is characterized by periodic paralysis and permanent muscle weakness.
  • Fat replacement in muscles is associated with permanent weakness in HypoPP.
  • The precise factors contributing to reduced muscle function beyond fat infiltration remain unclear.

Purpose of the Study:

  • To investigate muscle fat replacement and contractility in individuals with HypoPP-causing CACNA1S variants.
  • To compare muscle characteristics and function between HypoPP patients and healthy controls.

Main Methods:

  • Cross-sectional study utilizing T1-weighted and 2-point Dixon MRI for fat assessment.
  • Stationary dynamometry was employed to measure muscle strength.
  • Muscle contractility was calculated by dividing maximal muscle contraction by contractile cross-sectional muscle area.

Main Results:

  • Increased fat fraction was observed in ankle dorsiflexors and knee flexors/extensors in HypoPP patients.
  • Reduced muscle strength was noted in knee flexors and extensors compared to controls.
  • Decreased thigh muscle contractility was evident in individuals with HypoPP-causing CACNA1S variants.

Conclusions:

  • Decreased muscle contractility in HypoPP may stem from voltage-gated calcium channel dysfunction, subclinical paralysis, or altered muscle architecture.
  • Further investigation is required to elucidate the underlying mechanisms of reduced contractility.